Mortality in members of HIV-1 serodiscordant couples in Africa and implications for antiretroviral therapy initiation: Results of analyses from a multicenter randomized trial

Table 1 Demographic and clinical characteristics, by partner type

Characteristic	HIV-1 infected partner		HIV-1-uninfected partner
	(N = 3295)		(N = 3295)
	Men	Women	Men	Women
	(n = 1073)	(n = 2222)	(n = 2222)	(n = 1073)
Age, median (IQR)	37 (32,45)	30 (25, 35)	35 (30, 42)	31 (25, 38)
Informal settlement^¶	404 (38%)	859 (39%)	869 (39%)	390 (39%)
Married to study partner	866 (81%)	1627 (73%)	1636 (74%)	864 (81%)
Cohabiting with study partner	1002 (93%)	1970 (89%)	1983 (89%)	1000 (93%)
>8 years of education completed	512 (48%)	901 (41%)	1157 (52%)	401 (37%)
Any income	638 (59%)	546 (25%)	1331 (60%)	280 (26%)
CD4, median, cells/mm³ (IQR)			-	-
Enrollment	426 (334, 571)	481 (354, 664)
Final visit	394 (276, 544)	437 (312, 617)
HIV-1 plasma RNA, median, log₁₀ copies/mL (IQR)			-	-
Enrollment	4.2 (3.5, 4.8)	3.8 (3.0, 4.4)
Final visit	4.4 (3.6, 5.0)	4.0 (3.2, 4.7)
Ever on ART over follow up	112 (10%)	178 (8%)	-	-
Highest WHO stage of HIV-1			-	-
< 3	806 (75%)	1720 (77%)
3	243 (23%)	436 (20%)
4	24 (2%)	66 (3%)

ISSN: 1471-2334